Showing results (331-340 of 465) with videos related to

Sort By:
Pageof 47
European Urology Open Science|June 16, 2025
Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Roman Mayr, Danijel Sikic, et al.
Urologia Internationalis|August 21, 2014
Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomyAtiqullah Aziz, Michael Rink, Georgios Gakis, et al.
World Journal of Urology|August 12, 2024
Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patientsRoman Mayr, Simon Udo Engelmann, Yushan Yang, et al.
European Urology|July 20, 2015
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
Frontiers in Bioengineering and Biotechnology|April 18, 2015
Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineMikaël M Martino, Sime Brkic, Emmanuela Bovo, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple?Florian Roghmann, Peter J Goebell, Lars Dyrskjøt, et al.
Cells|August 9, 2020
Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder CancerDafina Ilijazi, Walter Pulverer, Iris E Ertl, et al.
World Journal of Urology|October 2, 2010
Gender differences in radical nephroureterectomy for upper tract urothelial carcinomaShahrokh F Shariat, Ricardo L Favaretto, Amit Gupta, et al.
The Journal of Urology|December 21, 2012
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomyEvanguelos Xylinas, Michael Rink, Vitaly Margulis, et al.
European Urology|March 30, 2022
Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin ImmunotherapyRoman Mayr, Markus Eckstein, Ralph M Wirtz, et al.
Pageof 47